Synthesis of 1alpha-fluoro-25-hydroxy-16-23e-diene26,27-bishomo-20-epi-cholecalciferol

Details for Australian Patent Application No. 2006279331 (hide)

Owner Bioxell S.p.A.

Inventors Uskokovic, Milan R.; Maehr, Hubert; Sluis, Marcel Van Der; Loo, Ralf; Jankowski, Pawel; Marczak, Stanislaw

Agent David Adamthwaite

Pub. Number AU-A-2006279331

PCT Pub. Number WO2007/022433

Priority 60/709,703 18.08.05 US

Filing date 18 August 2006

Wipo publication date 22 February 2007

International Classifications

C07C 401/00 (2006.01) Irradiation products of cholesterol or its derivatives

Event Publications

13 March 2008 PCT application entered the National Phase

  PCT publication WO2007/022433 Priority application(s): WO2007/022433

19 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006279332-Anti-inflammatory activity of phenethylisothiocyanate (PEITC) and the Barbarea verna seed preparation containing this compound

2006279327-Method and apparatus for detecting a wireless communication network in overlapping frequency bands